Use access key #2 to skip to page content.
$0.52 0.06 (12.78%)
10/13/2008 3:59 PM

AVANIR Pharmaceuticals (AVNR)

CAPS Rating:
*

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

AVNR doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

67 Outperforms
46 Underperforms
 

All-Stars

20 Outperforms
18 Underperforms
 

Wall Street

0 Outperforms
2 Underperforms
 

Members bullish on AVNR are also bullish on:

Members bearish on AVNR are also bearish on:

Ticker Tags

Drug Manufacturers - Other (105), Business Services (164), Micro Cap (4824)
Suggest a tag

AVANIR Pharmaceuticals At A Glance

Current Price: $0.52
Last Trade Time: 10/13/2008 3:59 PM
Open: $0.49
Previous Close: $0.46
Daily Range: $0.49 - $0.53
52-Week Range: $0.40 - $2.22
Volume: 153,933
Market Cap: $35.97M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

AVNR VS S&P 500 (SPY)

AVNR 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for AVNR.

Top Bull Pitch

Recs

1

AVANIR Pharmaceuticals (AVNR)

Avatar entropy2 (33.09) Submitted: 5/06/07 10:43 PM

Pure speculation stock - but better odds than the lottery.

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

AVANIR Pharmaceuticals (AVNR)

Avatar TrueNate (< 20) Submitted: 6/12/07 10:52 PM

this stock will not recover..., It's earnings have slid since last year, and what I predict is that they'll need a miracle drug to save them now...., I doubt this pill will help them out very much.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 19 :   1 2 3 4 Next »

Show Pitch Replies

Recs

0

 (AVNR)

Avatar jss6439 (< 20) Submitted: 7/03/07 5:16 PM : Underperform Start Price: $2.69 AVNR Score: 39.74

I just sold this stock knowing it is going to underperform.If your'e a player it has its moments but catch on the downside.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AVNR)

Avatar TrueNate (< 20) Submitted: 6/12/07 10:52 PM : Underperform Start Price: $3.25 AVNR Score: 43.80

this stock will not recover..., It's earnings have slid since last year, and what I predict is that they'll need a miracle drug to save them now...., I doubt this pill will help them out very much.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVNR)

Avatar trevormccoy (< 20) Submitted: 6/02/07 12:29 PM : Outperform Start Price: $3.29 AVNR Score: -42.81

Follow up Phase III data coming soon.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVNR)

Avatar praslee (< 20) Submitted: 5/29/07 6:54 PM : Underperform Start Price: $3.02 AVNR Score: 42.21

There is no near sight of anything big. The stock is already doubled since the last news. So it is time to cool off.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVNR)

Avatar AGAPE1646 (85.84) Submitted: 5/11/07 1:26 AM : Outperform Start Price: $2.73 AVNR Score: -41.06

AVNR has reached the bottom of its price range as a result of the 'approvable' FDA letter for Zenvia.


AVNR is making the right moves by downsizing R&D and conserving cash to fund the 2nd round PhIII clinical it will need to perform.


Zenvia has two good (and nearly unique) neurological indications - involuntary emotional expression disorder and diabetic neuropathy.


AVNR will need to raise cash (sell assets) or sell the company, so a good buyout premium is likely. This is most suitable as a short term investment.

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 19 :   1 2 3 4 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLazardCapit 75.03 11/01/06 Underperform NS $3.95-86.87%-34.92%+51.94
TrackJimCramer 77.11 10/13/06 Underperform 3W $8.70-94.04%-34.07%+59.96

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners